You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IgA Nephropathy

Showing 1 - 25 of 1,239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary IgA Nephropathy Trial (HRS-5965, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Nov 14, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
May 2, 2023

Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • SHR-2010 Injection
  • Placebo
  • (no location specified)
Apr 27, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Primary IgA Nephropathy Trial (RO7434656, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Mar 22, 2023

IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Oct 25, 2022

Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

Not yet recruiting
  • Glomerulonephritis, IGA
  • Blood collection
  • Urine sample
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Mar 17, 2023

IgA Nephropathy Trial in Shanghai

Recruiting
  • IgA Nephropathy
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai JiaoTong University School of Medicine
    Nov 1, 2022

    Link Between Complement Activation and IgA Nephropathy Severity

    Recruiting
    • IgA Nephropathy Severity in Kidney Transplantation
    • IgAN patients
    • Strasbourg, France
      Service de néphrologie
    Aug 18, 2022

    IgA Nephropathy Trial in Shanghai (rituximab group)

    Active, not recruiting
    • IgA Nephropathy
    • rituximab group
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Apr 9, 2023

    IgA Nephropathy Trial (CM338)

    Not yet recruiting
    • IgA Nephropathy
    • CM338
    • (no location specified)
    Mar 7, 2023

    Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)

    Not yet recruiting
    • Glomerulonephritis, IGA
    • (no location specified)
    Aug 19, 2022

    Primary IgA Nephrology Trial in Beijing (Nefecon)

    Not yet recruiting
    • Primary IgA Nephrology
    • Beijing, Beijing, China
      Peking University First Hospital
    Sep 6, 2022

    IgA Nephropathy Trial in Doral, Kyiv (AVB-S6-500)

    Terminated
    Has Results
    • IgA Nephropathy
    • Doral, Florida
    • +1 more
    Jan 18, 2022

    IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)

    Active, not recruiting
    • IgA Nephropathy (IgAN)
    • +2 more
    • Vancouver, British Columbia, Canada
    • +19 more
    Jan 13, 2023

    Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

    Not yet recruiting
    • Diabetic Kidney Disease
    • IgA Nephropathy
    • Placebo of SC0062
    • +3 more
    • (no location specified)
    Jan 9, 2023

    Correlation of Microbiome and Metabonomics With IgA Nephropathy

    Recruiting
    • IgA Nephropathy
      • Guangzhou, Guangdong, China
      • +4 more
      Jan 12, 2022

      IgA Nephropathy, IgAN Trial in Worldwide (AT-1501)

      Recruiting
      • IgA Nephropathy
      • IgAN
      • Liverpool, South Wales, Australia
      • +23 more
      Dec 5, 2022

      IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

      Recruiting
      • IgA Nephropathy
      • Focal Segmental Glomerulosclerosis
      • HS-10390 tablet
      • Placebo tablet
      • Nanjing, Jiangsu, China
        Zhongda Hospital, Affiliated to Southeast University
      Jul 12, 2023

      IgA Nephropathy Biomarkers Evaluation Study (INTEREST)

      Recruiting
      • IgA Nephropathy
      • Glomerular Diseases
      • No intervention
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital,Sun Yat-sen University
      Sep 21, 2021

      IgA Nephropathy Trial in Guangzhou (tonsillectomy, non-tonsillectomy)

      Suspended
      • IgA Nephropathy
      • tonsillectomy
      • non-tonsillectomy
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital of Sun Yat-sen University
      Sep 21, 2021

      Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

      Recruiting
      • Bortezomib
      • +5 more
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Oct 28, 2022

      IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment Trial in Beijing (Corticosteroid, Cyclophosphamide,

      Recruiting
      • IgA Nephropathy
      • +2 more
      • Beijing, China
        Peking University First Hospital
      Apr 21, 2022

      IgA Nephropathy at High Risk of Developing ESRD Trial in Beijing (The Yi-Qi-Qing-Jie herbal compound, Immunosuppressants,

      Recruiting
      • IgA Nephropathy at High Risk of Developing ESRD
      • The Yi-Qi-Qing-Jie herbal compound
      • +3 more
      • Beijing, Beijing, China
        Guang anmen Hospital, China Academy of Chinese Medical Sciences
      Mar 15, 2022

      Glomerulonephritis , IGA Trial in Kasugai, Nagoya (infusion of ADR-001 (Mesenchymal stem cell))

      Active, not recruiting
      • Glomerulonephritis , IGA
      • infusion of ADR-001 (Mesenchymal stem cell)
      • Kasugai, Aichi, Japan
      • +1 more
      Nov 10, 2021